Xiushi
Latest round
- Series A
Last raised
- Aug 2025
Total raised
- Undisclosed
Investors
- 5
About Xiushi
, Ltd, trading as Xiushi, is a biomedical company that focuses on providing peptide drug biosynthesis solutions for industry partners. The core team is composed of technical experts in the fields of pharmaceutical engineering, fermentation engineering, and protein engineering. It was recognized as the National High-tech Enterprise. The company's main business is the research and development, manufacturing, and sales of APIs and preparations for recombinantly expressed peptide or protein innovative drugs. Its products cover innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides, and protein products. Its biosynthesis strategy has been validated on several short peptides and complex cyclic peptides, which provides capacity building and cost advantages over traditional biological and chemical synthesis methods. The company’s revenue is generated by providing synthetic industrial enzymes, functional peptides, and protein products, etc.
Who invested in Xiushi
5 investors across 2 rounds
See all investors in Xiushi
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xiushi
Who invested in Xiushi?
Xiushi has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xiushi raised?
Xiushi has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Xiushi last raise money?
Xiushi's most recent round on record is a Series A, in Aug 2025.
What does Xiushi do?
, Ltd, trading as Xiushi, is a biomedical company that focuses on providing peptide drug biosynthesis solutions for industry partners.
Where is Xiushi headquartered?
Xiushi is headquartered in Nantong, China.
Which VCs invest in companies like Xiushi?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Xiushi's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Xiushi? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.